INTERNATIONAL PATENT: CORNOVUS PHARMACEUTICALS, INC. FILES APPLICATION FOR "CRYSTALLINE FORMS AND SALT FORMS OF A CARDIAC P2X RECEPTOR AGONIST, PHARMACEUTICAL COMPOSITIONS AND THEIR USE IN TREATING MEDICAL DISORDERS"

GENEVA, Dec. 17 -- CORNOVUS PHARMACEUTICALS, INC. (261 Saint Ronan StreetNew Haven, Connecticut 06511) filed a patent application (PCT/US2025/031992) for "CRYSTALLINE FORMS AND SALT FORMS OF A CARDIAC P2X RECEPTOR AGONIST, PHARMACEUTICAL COMPOSITIONS, AND THEIR USE IN TREATING MEDICAL DISORDERS" on Jun 03, 2025. With publication no. WO/2025/255059, the details related to the patent application was published on Dec 11, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): JONAITIS, David T. (c/o Triclinic Labs2660 Schuyler Avenue, Suite ALafayette, Indiana 47905), GROVE, Lisa Michelle (c/o Triclini...